Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Steven Schild

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Disorders

Procedures

Phenomena

Karnofsky Performance Status

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
65
Rades, Dirk
27
Dunst, Jürgen
27
Veninga, Theo
19
Stalpers, Lukas
12
Fehlauer, Fabian
12
Hoskin, Peter
11
Rudat, Volker
10
Alberti, Winfried
8
Karstens, Johann
8
Schulte, Rainer
7
Basic, Hiba
6
Lohynska, Radka
5
Pluemer, Andre
5
Wildfang, Ingeborg
4
Tribius, Silke

Sign-in to see all Coauthors

Publications

TOP 3
Rades Dirk; Wolff Christian; Nadrowitz Roger; Breunig Christian; Schild Steven E; Baehre Manfred; Meller Birgit
Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy.
Tribius Silke; Kronemann Stefanie; Kilic Yasemin; Schroeder Ursula; Hakim Samer; Schild Steven E; Rades Dirk
Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.
Rades Dirk; Fischer Dorothea; Veninga Theo; Stalpers Lukas J A; Schild Steven E
Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Steven Schild (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Rades Dirk; Wolff Christian; Nadrowitz Roger; Breunig Christian; Schild Steven E; Baehre Manfred; Meller Birgit
Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy.
International journal of radiation oncology, biology, physics 2009;75(4):1226-31.
2009: Tribius Silke; Kronemann Stefanie; Kilic Yasemin; Schroeder Ursula; Hakim Samer; Schild Steven E; Rades Dirk
Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(10):675-81.
2009: Rades Dirk; Fischer Dorothea; Veninga Theo; Stalpers Lukas J A; Schild Steven E
Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.
Gynecologic oncology 2009;114(3):506-8.
2009: Rades Dirk; Kueter Jan-Dirk; Pluemer Andre; Veninga Theo; Schild Steven E
A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
International journal of radiation oncology, biology, physics 2009;73(4):1077-81.
2009: Rades Dirk; Kueter Jan-Dirk; Veninga Theo; Gliemroth Jan; Schild Steven E
Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matched pair analysis.
European journal of cancer (Oxford, England : 1990) 2009;45(3):400-4.
2009: Sengpiel C; König I R; Rades D; Noack F; Duchrow M; Schild S E; Ludwig D; Homann N
p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.
Cancer investigation 2009;27(1):96-104.
2008: Rades Dirk; Kueter Jan-Dirk; Hornung Dagmar; Veninga Theo; Hanssens Patrick; Schild Steven E; Dunst Juergen
Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(12):655-62.
2008: Rades Dirk; Pluemer Andre; Veninga Theo; Schild Steven E
Comparison of different treatment approaches for one to two brain metastases in elderly patients.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(11):565-71.
2008: Rades Dirk; Rudat Volker; Veninga Theo; Stalpers Lukas J A; Basic Hiba; Karstens Johann H; Hoskin Peter J; Schild Steven E
A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.
International journal of radiation oncology, biology, physics 2008;72(3):905-8.
2008: Rades Dirk; Rudat Volker; Veninga Theo; Stalpers Lukas J A; Hoskin Peter J; Schild Steven E
Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
Cancer 2008;113(5):1090-6.
2008: Rades Dirk; Golke Helmut; Schild Steven E; Kilic Ergin
Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(8):416-20.
2008: Rades Dirk; Setter Cornelia; Schild Steven E; Dunst Juergen
Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2008;71(4):1134-42.
2008: Rades Dirk; Dunst Juergen; Schild Steven E
A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(5):251-5.
2008: Rades Dirk; Golke Helmut; Schild Steven E; Kilic Ergin
The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.
International journal of radiation oncology, biology, physics 2008;71(1):152-9.
2008: Rades Dirk; Stoehr Monika; Meyners Thekla; Bohlen Guenther; Nadrowitz Roger; Dunst Juergen; Schild Steven E; Wroblewski Junes; Albers Dirk; Schmidt Rainer; Alberti Winfried; Tribius Silke
Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(4):198-205.
2008: Rades Dirk; Kieckebusch Susanne; Haatanen Tiina; Lohynska Radka; Dunst Juergen; Schild Steven E
Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis.
International journal of radiation oncology, biology, physics 2008;70(5):1319-24.
2008: Rades Dirk; Schild Steven E
A comparison of chemotherapy plus surgery with surgery alone for localized esophageal cancer.
Nature clinical practice. Oncology 2008;5(4):190-1.
2008: Rades Dirk; Stoehr Monika; Kazic Nadja; Hakim Samer G; Walz Annette; Schild Steven E; Dunst Juergen
Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy.
International journal of radiation oncology, biology, physics 2008;70(4):1108-14.
2008: Rades Dirk; Kuhn Hildegard; Schultze Juergen; Homann Nils; Brandenburg Bernd; Schulte Rainer; Krull Andreas; Schild Steven E; Dunst Juergen
Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin.
International journal of radiation oncology, biology, physics 2008;70(4):1087-93.
2008: Rades Dirk; Fehlauer Fabian; Sheikh-Sarraf Mashid; Kazic Nadja; Basic Hiba; Poorter Robert; Hakim Samer G; Schild Steven E; Dunst Juergen
Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer.
Head & neck 2008;30(2):235-41.
2008: Rades Dirk; Bohlen Guenther; Dunst Juergen; Lohynska Radka; Veninga Theo; Stalpers Lukas; Schild Steven E; Dahm-Daphi Jochen
Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(1):30-5.
2008: Rades Dirk; Dunst Juergen; Schild Steven E
The first score predicting overall survival in patients with metastatic spinal cord compression.
Cancer 2008;112(1):157-61.
2007: Rades Dirk; Lohynska Radka; Veninga Theo; Stalpers Lukas J A; Schild Steven E
Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Cancer 2007;110(11):2587-92.
2007: Rades Dirk; Kieckebusch Susanne; Lohynska Radka; Veninga Theo; Stalpers Lukas J A; Dunst Juergen; Schild Steven E
Reduction of overall treatment time in patients irradiated for more than three brain metastases.
International journal of radiation oncology, biology, physics 2007;69(5):1509-13.
2007: Rades Dirk; Bohlen Guenther; Lohynska Radka; Veninga Theo; Stalpers Lukas J A; Schild Steven E; Dunst Juergen
Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(11):631-6.
2007: Rades Dirk; Pluemer Andre; Veninga Theo; Hanssens Patrick; Dunst Juergen; Schild Steven E
Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.
Cancer 2007;110(10):2285-92.
2007: Olivier Kenneth R; Schild Steven E; Morris Christopher G; Brown Paul D; Markovic Svetomir N
A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma.
Cancer 2007;110(8):1791-5.
2007: Rades Dirk; Pluemer Andre; Veninga Theo; Dunst Juergen; Schild Steven E
A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Cancer 2007;110(7):1551-9.
2007: Rades Dirk; Haatanen Tiina; Schild Steven E; Dunst Juergen
Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
Cancer 2007;110(6):1345-50.
2007: Rades Dirk; Schild Steven E
Is surgery necessary following chemoradiation for patients with locally advanced cancer of the esophagus?
Nature clinical practice. Oncology 2007;4(9):506-7.
2007: Rades Dirk; Schild Steven E; Lohynska Radka; Veninga Theo; Stalpers Lukas J A; Dunst Juergen
Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
Cancer 2007;110(5):1077-82.
2007: Rades Dirk; Schwarz Rudolf; Todorovic Manuel; Thurmann Horst; Graefen Markus; Walz Jochen; Schild Steven E; Dunst Juergen; Alberti Winfried
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(7):398-402.
2007: Rades Dirk; Schild Steven E
Is stereotactic radiosurgery the best treatment option for patients with spinal metastases?
Nature clinical practice. Oncology 2007;4(7):400-1.
2007: Rades Dirk; Fehlauer Fabian; Wroblesky Junes; Albers Dirk; Schild Steven E; Schmidt Rainer
Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.
Oral oncology 2007;43(6):535-43.
2007: Rades Dirk; Walz Jochen; Schild Steven E; Veninga Theo; Dunst Juergen
Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone?
Urology 2007;69(6):1081-5.
2007: Rades Dirk; Bohlen Guenther; Pluemer Andre; Veninga Theo; Hanssens Patrick; Dunst Juergen; Schild Steven E
Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Cancer 2007;109(12):2515-21.
2007: Rades Dirk; Veninga Theo; Stalpers Lukas J A; Basic Hiba; Hoskin Peter J; Karstens Johann H; Schild Steven E; Dunst Juergen
Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression.
International journal of radiation oncology, biology, physics 2007;67(5):1506-9.
2007: Rades Dirk; Karstens Johann H; Hoskin Peter J; Rudat Volker; Veninga Theo; Schild Steven E; Dunst Juergen
Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
International journal of radiation oncology, biology, physics 2007;67(2):525-31.
2007: Rades Dirk; Fehlauer Fabian; Veninga Theo; Stalpers Lukas J A; Basic Hiba; Hoskin Peter J; Rudat Volker; Karstens Johann H; Schild Steven E; Dunst Juergen
Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
International journal of radiation oncology, biology, physics 2007;67(2):532-7.
2007: Rades D; Schild S E; Dunst J
Radiotherapy is effective for metastatic spinal cord compression in patients with epithelial ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(1):263-5.
2007: Rades Dirk; Schulte Rainer; Yekebas Emre F; Homann Nils; Schild Steven E; Dunst Juergen
Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(1):10-6.
2007: Rades Dirk; Veninga Theo; Stalpers Lukas J A; Basic Hiba; Rudat Volker; Karstens Johann H; Dunst Juergen; Schild Steven E
Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):50-6.
2007: Rades Dirk; Hoskin Peter J; Karstens Johann H; Rudat Volker; Veninga Theo; Stalpers Lukas J A; Schild Steven E; Dunst Juergen
Radiotherapy of metastatic spinal cord compression in very elderly patients.
International journal of radiation oncology, biology, physics 2007;67(1):256-63.
2006: Rades Dirk; Fehlauer Fabian; Schulte Rainer; Veninga Theo; Stalpers Lukas J A; Basic Hiba; Bajrovic Amira; Hoskin Peter J; Tribius Silke; Wildfang Ingeborg; Rudat Volker; Engenhart-Cabilic Rita; Karstens Johann H; Alberti Winfried; Dunst Juergen; Schild Steven E
Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3388-93.
2006: Rades Dirk; Schild Steven E
Is 50 Gy sufficient to achieve long-term local control after incomplete resection of typical neurocytomas?
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2006;182(7):415-8.
2006: Rades Dirk; Tribius Silke; Yekebas Emre F; Bahrehmand Roia; Wildfang Ingeborg; Kilic Ergin; Muellerleile Ulrich; Gross Eberhard; Schild Steven E; Alberti Winfried
Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study.
International journal of radiation oncology, biology, physics 2006;65(2):459-65.
2006: Rades Dirk; Stalpers Lukas J A; Schulte Rainer; Veninga Theo; Basic Hiba; Engenhart-Cabilic Rita; Schild Steven E; Hoskin Peter J
Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients.
European journal of cancer (Oxford, England : 1990) 2006;42(8):1052-6.
2006: Rades Dirk; Schild Steven E
Treatment recommendations for the various subgroups of neurocytomas.
Journal of neuro-oncology 2006;77(3):305-9.
2006: Rades Dirk; Walz Jochen; Stalpers Lukas J A; Veninga Theo; Schulte Rainer; Obralic Nermina; Wildfang Ingeborg; Engenhart-Cabilic Rita; Hoskin Peter J; Schild Steven E
Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study.
European urology 2006;49(5):846-52; discussion 852.
2006: Rades Dirk; Schild Steven E
Dose-response relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature.
Journal of neuro-oncology 2006;77(3):311-4.
2006: Rades Dirk; Hoskin Peter J; Stalpers Lukas J A; Schulte Rainer; Poortmans Philip; Veninga Theo; Dahm-Daphi Jochen; Obralic Nermina; Wildfang Ingeborg; Bahrehmand Roja; Engenhart-Cabilic Rita; Schild Steven E
Short-course radiotherapy is not optimal for spinal cord compression due to myeloma.
International journal of radiation oncology, biology, physics 2006;64(5):1452-7.
2006: Rades D; Lang S; Schild S E; Alberti W
Prognostic value of haemoglobin levels during concurrent radio-chemotherapy in the treatment of oesophageal cancer.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2006;18(2):139-44.
2006: Rades Dirk; Schild Steven E
Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas.
Cancer 2006;106(5):1140-3.
2006: Rades Dirk; Veninga Theo; Stalpers Lukas J A; Schulte Rainer; Hoskin Peter J; Poortmans Philip; Schild Steven E; Rudat Volker
Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
International journal of radiation oncology, biology, physics 2006;64(1):182-8.
2005: Rades Dirk; Schild Steven E; Yekebas Emre F; Job Hendric; Schwarz Rudolf; Rudat Volker
Epoetin-alpha during radiotherapy for stage III esophageal carcinoma.
Cancer 2005;103(11):2274-9.
2005: Rades Dirk; Stalpers Lukas J A; Veninga Theo; Schulte Rainer; Hoskin Peter J; Obralic Nermina; Bajrovic Amira; Rudat Volker; Schwarz Rudolf; Hulshof Maarten C; Poortmans Philip; Schild Steven E
Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3366-75.
2005: Rades Dirk; Schild Steven E; Bahrehmand Roja; Zschenker Oliver; Alberti Winfried A; Rudat Volker R
Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels.
Cancer 2005;103(8):1740-6.
2005: Rades Dirk; Fehlauer Fabian; Lamszus Katrin; Schild Steven E; Hagel Christian; Westphal Manfred; Alberti Winfried
Well-differentiated neurocytoma: what is the best available treatment?
Neuro-oncology 2005;7(1):77-83.
2005: Rades Dirk; Fehlauer Fabian; Ikezaki Kiyonobu; Schild Steven E
Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;74(1):67-9.
2004: Rades Dirk; Schild Steven E; Fehlauer Fabian
Defining the best available treatment for neurocytomas in children.
Cancer 2004;101(11):2629-32.
2004: Rades Dirk; Fehlauer Fabian; Stalpers Lukas J A; Wildfang Ingeborg; Zschenker Oliver; Schild Steven E; Schmoll Hans J; Karstens Johann H; Alberti Winfried
A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study.
Cancer 2004;101(11):2687-92.
2004: Rades Dirk; Schild Steven E; Tatagiba Marcos; Molina Hugo A; Alberti Winfried
Therapy of meningeal melanocytomas.
Cancer 2004;100(11):2442-7.
2004: Rades Dirk; Schild Steven E; Fehlauer Fabian
Prognostic value of the MIB-1 labeling index for central neurocytomas.
Neurology 2004;62(6):987-9.
2004: Rades Dirk; Fehlauer Fabian; Schild Steven E
Treatment of atypical neurocytomas.
Cancer 2004;100(4):814-7.
2003: Rades Dirk; Fehlauer Fabian; Schild Steven; Lamszus Karin; Alberti Winfried
[Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients]
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(4):213-8.
2003: Rades Dirk; Schild Steven E; Ikezaki Kiyonobu; Fehlauer Fabian
Defining the optimal dose of radiation after incomplete resection of central neurocytomas.
International journal of radiation oncology, biology, physics 2003;55(2):373-7.

Sign-in to see more